NanoViricides, Inc.
Cash Flow Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-8.6M | $-10.3M | $-10.7M | $-2.2M | $-13.6M | $-8.9M | $-6.2M | $-6.5M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $671.8K | $654.7K | $651.3K | $294.2K | $203.2K | $210.9K | $210.9K | $519.0K |
| Amortization | $8.3K | $8.3K | — | — | — | — | — | — |
| Stock-Based Compensation | $156.2K | — | $158.0K | — | — | — | — | — |
| Net Cash from Operating Activities | $-7.8M | $-7.9M | $-6.8M | $-6.2M | $-6.3M | $-5.8M | $-4.2M | $-4.5M |
| Investing Activities | ||||||||
| Capital Expenditures | $241.8K | $165.0K | $476.4K | $6.8M | $5.2M | $64.9K | $23.4K | $153.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | $-1.1M | $-58.6K | $-194.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $0 | $-1.0M | — | — | — | $6.5M | $9.3M | $7.0M |
| Net Change in Cash | $-8.0M | $-9.1M | $-7.3M | $-5.2M | $22.8M | $-351.7K | $5.1M | $2.3M |
| Free Cash Flow | $-8.0M | $-8.1M | $-7.3M | $-13.0M | $-11.6M | $-5.9M | $-4.2M | $-4.7M |